{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:04:11Z","timestamp":1788311051620,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bcp.2017.10.008","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T12:30:20Z","timestamp":1508502620000},"page":"63-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Lawsone derivatives target the Wnt\/\u03b2-catenin signaling pathway in multidrug-resistant acute lymphoblastic leukemia cells"],"prefix":"10.1016","volume":"146","author":[{"given":"Sami","family":"Hamdoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2017.10.008_b0005","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute lymphoblastic leukemia","volume":"350","author":"Pui","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2017.10.008_b0010","unstructured":"S. Fulda, Evasion of apoptosis as a cellular stress response in cancer."},{"key":"10.1016\/j.bcp.2017.10.008_b0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2017.10.008_b0020","doi-asserted-by":"crossref","first-page":"36754","DOI":"10.1038\/srep36754","article-title":"Genomic and transcriptomic profiling of resistant CEM\/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance","volume":"6","author":"Kadioglu","year":"2016","journal-title":"Scientific Rep."},{"key":"10.1016\/j.bcp.2017.10.008_b0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1586\/14789450.2.2.215","article-title":"Proteomic approaches for studying chemoresistance in cancer","volume":"2","author":"Righetti","year":"2005","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.bcp.2017.10.008_b0030","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.febslet.2005.12.060","article-title":"The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research","volume":"580","author":"Gottesman","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2017.10.008_b0035","first-page":"237","article-title":"Chemotherapy-induced resistance by ATP-binding cassette transporter genes","volume":"1775","author":"Gillet","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2017.10.008_b0040","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-017-1938-5","article-title":"Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers","author":"Efferth","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2017.10.008_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4615-4811-9_1","article-title":"MDR1\/P-GP expression as a prognostic factor in acute leukemias","volume":"457","author":"Marie","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2017.10.008_b0050","series-title":"Resistance to Targeted ABC Transporters in Cancer","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-09801-2_1","article-title":"Role of P-glycoprotein for resistance of tumors to anticancer drugs: from bench to bedside","author":"Volm","year":"2015"},{"key":"10.1016\/j.bcp.2017.10.008_b0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/15680096113139990076","article-title":"P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives","volume":"13","author":"Binkhathlan","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bcp.2017.10.008_b0060","first-page":"21","article-title":"Marine natural products as models to circumvent multidrug resistance","author":"Long","year":"2016","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.bcp.2017.10.008_b0065","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.phymed.2016.01.008","article-title":"beta-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function","volume":"23","author":"Teng","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2017.10.008_b0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral sensitivity as a strategy against cancer multidrug resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resistance Updates"},{"key":"10.1016\/j.bcp.2017.10.008_b0075","series-title":"Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance","first-page":"187","article-title":"Collateral sensitivity in drug-resistant tumor cells","author":"Saeed","year":"2013"},{"key":"10.1016\/j.bcp.2017.10.008_b0080","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1021\/acs.jnatprod.5b00158","article-title":"Miltirone induces G2\/M cell cycle arrest and apoptosis in CCRF-CEM acute lymphoblastic leukemia cells","volume":"78","author":"Wu","year":"2015","journal-title":"J. Natural Prod."},{"key":"10.1016\/j.bcp.2017.10.008_b0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2016.06.002","article-title":"Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines","volume":"305","author":"Ooko","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.008_b0090","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tips.2009.07.003","article-title":"Is resistance useless? Multidrug resistance and collateral sensitivity","volume":"30","author":"Hall","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2017.10.008_b0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2017.10.008_b0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/org.4.2.5851","article-title":"Wnt signal transduction pathways","volume":"4","author":"Komiya","year":"2008","journal-title":"Organogenesis"},{"key":"10.1016\/j.bcp.2017.10.008_b0105","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nrd2154","article-title":"Mining the Wnt pathway for cancer therapeutics","volume":"5","author":"Barker","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2017.10.008_b0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2052-8426-2-28","article-title":"Targeting the Wnt pathways for therapies","volume":"2","author":"Blagodatski","year":"2014","journal-title":"Mol. Cell. Therapies"},{"key":"10.1016\/j.bcp.2017.10.008_b0115","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008052","article-title":"Wnt signaling in cancer","volume":"4","author":"Polakis","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.bcp.2017.10.008_b0120","first-page":"6793","article-title":"Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells","volume":"50","author":"Kimmig","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2017.10.008_b0125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/mol.64.2.382","article-title":"Molecular modes of action of artesunate in tumor cell lines","volume":"64","author":"Efferth","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2017.10.008_b0130","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcp.2017.10.008_b0135","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","article-title":"Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells","volume":"22","author":"Ooko","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2017.10.008_b0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jsbmb.2015.03.008","article-title":"Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na(+)\/K(+)-ATPase","volume":"150","author":"Zeino","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bcp.2017.10.008_b0145","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.phymed.2016.04.007","article-title":"Cytotoxicity of seven naturally occurring phenolic compounds towards multi-factorial drug-resistant cancer cells","volume":"23","author":"Kuete","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2017.10.008_b0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1534-5807(03)00266-1","article-title":"A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling","volume":"5","author":"Veeman","year":"2003","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcp.2017.10.008_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1126\/science.1222879","article-title":"Structural basis of Wnt recognition by Frizzled","volume":"337","author":"Janda","year":"2012","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bcp.2017.10.008_b0160","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1023\/A:1026538713236","article-title":"Acute lymphoblastic leukaemia in puberty and adolescence","volume":"11","author":"van den Berg","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bcp.2017.10.008_b0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pcl.2014.09.006","article-title":"Treatment of pediatric acute lymphoblastic leukemia","volume":"62","author":"Cooper","year":"2015","journal-title":"Pediatric Clin. North America"},{"key":"10.1016\/j.bcp.2017.10.008_b0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2017.10.008_b0175","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1182\/blood.V81.9.2394.2394","article-title":"Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications","volume":"81","author":"Goasguen","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2017.10.008_b0180","first-page":"261","article-title":"The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia","volume":"78","author":"Savignano","year":"1993","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2017.10.008_b0185","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1182\/blood.V91.6.2092.2092_2092_2098","article-title":"Relationship between major vault protein\/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia","volume":"91","author":"den Boer","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2017.10.008_b0190","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1365-2141.1999.01378.x","article-title":"P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study","volume":"105","author":"Dhooge","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcp.2017.10.008_b0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/MPH.0b013e3181a974b3","article-title":"P-glycoprotein activity predicts outcome in childhood acute lymphoblastic leukemia","volume":"31","author":"Brozek","year":"2009","journal-title":"J. Pediatric Hematol.\/Oncol."},{"key":"10.1016\/j.bcp.2017.10.008_b0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrc1587","article-title":"Chemical approaches to the discovery and development of cancer therapies","volume":"5","author":"Neidle","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2017.10.008_b0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4161\/15384047.2014.987093","article-title":"Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells","volume":"16","author":"Chong","year":"2015","journal-title":"Cancer Biol. Therapy"},{"key":"10.1016\/j.bcp.2017.10.008_b0210","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/cas.12223","article-title":"Inhibition of Wnt\/beta-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma","volume":"104","author":"Shen","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2017.10.008_b0215","unstructured":"Y.Y. Liu, V. Gupta, G.A. Fau \u2013 Patwardhan, G.A. Patwardhan, K. Fau \u2013 Bhinge, K. Bhinge, Y. Fau \u2013 Zhao, Y. Zhao, J. Fau \u2013 Bao, J. Bao, H. Fau \u2013 Mehendale, et al., Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling."},{"key":"10.1016\/j.bcp.2017.10.008_b0220","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/1078-0432.CCR-14-0877","article-title":"Molecular pathways: aspirin and Wnt signaling-a molecularly targeted approach to cancer prevention and treatment","volume":"21","author":"Gala","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2017.10.008_b0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcp.2017.10.008_b0230","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2164-15-74","article-title":"Comprehensive analysis of beta-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt\/beta-catenin signaling","volume":"15","author":"Herbst","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bcp.2017.10.008_b0235","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/onc.2008.312","article-title":"Apoptotic signaling by c-MYC","volume":"27","author":"Hoffman","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2017.10.008_b0240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0165-6147(98)01246-2","article-title":"Frizzled proteins constitute a novel family of G protein-coupled receptors, most closely related to the secretin family","volume":"19","author":"Barnes","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2017.10.008_b0245","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm3470","article-title":"The complex world of WNT receptor signalling","volume":"13","author":"Niehrs","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2017.10.008_b0250","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1038\/sj.emboj.7600817","article-title":"The role of the cysteine-rich domain of Frizzled in Wingless-Armadillo signaling","volume":"24","author":"Povelones","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2017.10.008_b0255","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/18899","article-title":"A new secreted protein that binds to Wnt proteins and inhibits their activities","volume":"398","author":"Hsieh","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2017.10.008_b0260","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1073\/pnas.1618293114","article-title":"Unsaturated fatty acyl recognition by Frizzled receptors mediates dimerization upon Wnt ligand binding","volume":"114","author":"Nile","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2017.10.008_b0265","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bmcl.2013.01.101","article-title":"Small molecule modulators of Wnt\/\u03b2-catenin signaling","volume":"23","author":"Mook","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2017.10.008_b0270","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2407-12-303","article-title":"Wnt\/beta-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia","volume":"12","author":"Correa","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2017.10.008_b0275","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2017.10.008_b0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.abb.2009.09.012","article-title":"P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil","volume":"491","author":"Laberge","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2017.10.008_b0285","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phymed.2015.01.002","article-title":"Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells","volume":"22","author":"Abdelfatah","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2017.10.008_b0290","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.phymed.2015.01.012","article-title":"Cytotoxicity of natural products and derivatives toward MCF-7 cell monolayers and cancer stem-like mammospheres","volume":"22","author":"Seo","year":"2015","journal-title":"Phytomedicine"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521730638X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521730638X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T02:32:10Z","timestamp":1603161130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521730638X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":58,"alternative-id":["S000629521730638X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.10.008","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lawsone derivatives target the Wnt\/\u03b2-catenin signaling pathway in multidrug-resistant acute lymphoblastic leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}